A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer
Clinical trial NCT04995042 · COMPLETED
Trial details
- NCT number
- NCT04995042
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2023-05-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.